Hysteroscopic Septoplasty by Different Modalities
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to compare in participant population ( women with uterine septum meeting the inclusion criteria) hysteroscopic septoplasty by resectoscope compared to hysteroscopic septoplasty with scissors. The main questions to answer are: Is there a difference in operative time ? Is there a difference in fluid used and fluid deficit? Is there a difference in complications? Is there a difference in reproductive outcome? Researchers will compare the 2 different techniques to see if there is any difference in operative outcome ( operative time, fluid used and deficit, need for second intervention, and operative and postoperative complications) and reproductive outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2023
CompletedFirst Submitted
Initial submission to the registry
March 22, 2023
CompletedFirst Posted
Study publicly available on registry
April 7, 2023
CompletedApril 10, 2023
April 1, 2023
2.7 years
March 22, 2023
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Operative time
During surgery
Fluid deficit
During surgery
Operative and post operative complications
3 months follow up after intervention
Need for second intervention
3 months follow up after intervention
Secondary Outcomes (2)
Pregnancy rate
At least 6 months follow up after intervention
Live birth rate
Follow up until the end of first clinical pregnancy or 6 months after surgery
Study Arms (2)
Scissors arm
ACTIVE COMPARATORPatients in this group had undergone resection of the septum with hysteroscope and scissors, The scissors used was pointed, single action and semi rigid . Saline was used as the distending medium in the scissors group. Septal incision was carried out using shortening technique by incising the septum at the leading edge and continue dividing by moving from side to side (in narrow septum), or by thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other (in broad septum). The operation was stopped if the fluid deficit exceeded 2500 ml of saline.
Resectoscope arm
ACTIVE COMPARATORPatients in this group had undergone resection of the septum with Monopolar 26 French resectoscope Dilation of cervical os with Hegar's dilator (up to hegar 8 or 9) , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 40-70 Watt) and glycine 1.5% as the distension medium, using shortening or thinning incision. The operation was stopped if the fluid deficit exceeded 1000 ml of glycine. The delivery of distension media was conducted by automated pressure delivery system. All patients were prescribed cyclic estrogen and progesterone for two months.
Interventions
In hysteroscopic septoplasty with scissors arm, incision of the septum was done by continuous flow hysteroscopy and scissors using saline as distension media.
In hysteroscopic septoplasty with resectoscope arm, incision of the septum was done by 26 Fr monopolar resectoscope with collin's knife using glycine1.5% as distension media.
Eligibility Criteria
You may qualify if:
- Women of reproductive age
- Seeking conception
- Diagnosis of a septate or subseptate uterus
- A history of one of the following:
- Recurrent pregnancy loss
- Subfertility
- Preterm Birth
You may not qualify if:
- Not seeking conception
- Diagnosis of septate or subseptate uterus with no history of any of the following:
- Recurrent pregnancy loss
- Subfertility
- Preterm Birth
- Contraindications for surgery
- Those who refused to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine, Mansoura university
Al Mansurah, Dakahlia Governorate, 35511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer of Obstetrics and Gynecology
Study Record Dates
First Submitted
March 22, 2023
First Posted
April 7, 2023
Study Start
June 16, 2020
Primary Completion
March 1, 2023
Study Completion
March 21, 2023
Last Updated
April 10, 2023
Record last verified: 2023-04